Latest news
How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce PharmaFierce Pharma · Tue, 28 Jul 2026 07:00:00 GMTElevar Therapeutics Announces Three Abstracts Accepted for Presentation at ESMO Congress 2026 - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT